Latest Strategy News

Top End Energy has strategically expanded into the US AI data center sector, positioning itself as a key land and energy partner to meet surging power demands.

DeSoto Resources has advanced its exploration in Guinea’s Siguiri Basin with a new JV alongside Fortuna Mining and impressive high-grade gold intercepts, supported by a recent $14 million capital raise.

Equus Energy has launched on the ASX with full ownership of the Equus Gas Project, backed by a $46 million conditional funding and gas sales agreement with Alcoa. The project aims to supply a significant new gas source for Western Australia’s LNG and domestic markets.

Next Science Limited is set to distribute approximately A$0.145 per share following the sale of its assets to OSARTIS GmbH, marking a significant step towards winding down its operations.

Ragusa Minerals has raised $600,000 through a private placement to fund exploration at its Purple Pansy Manganese-Gold Project in Arizona, supported strongly by existing shareholders.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.

St George Mining has appointed a top Washington DC government relations firm to deepen its engagement with US agencies, advancing its Araxá rare earths project amid growing US efforts to secure critical mineral supply chains in the Western Hemisphere.

Advanced Metals has ramped up its drilling programs in Mexico and Australia, backed by a $13 million capital raise and strengthened leadership, positioning itself for significant resource growth in 2026.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Coronado Global Resources reported a solid FY25 with increased saleable production and reduced mining costs, underpinned by key expansions and refinancing deals that set the stage for stronger cash flow in 2026.

Following its December 2025 ASX debut and a successful IPO, Saluda Medical reports robust global revenue growth and expands its US sales force, prompting an upward revision of its FY26 revenue guidance.